Peter D. Suzdak
2014
In 2014, Peter D. Suzdak earned a total compensation of $1.4M as Chief Executive Officer at Rexahn Pharmaceuticals, a 98% increase compared to previous year.
Compensation breakdown
| Bonus | $150,500 |
|---|---|
| Option Awards | $881,566 |
| Salary | $368,462 |
| Other | $12,747 |
| Total | $1,413,275 |
Suzdak received $881.6K in option awards, accounting for 62% of the total pay in 2014.
Suzdak also received $150.5K in bonus, $368.5K in salary and $12.7K in other compensation.
Rankings
In 2014, Peter D. Suzdak's compensation ranked 6,041st out of 13,032 executives tracked by ExecPay. In other words, Suzdak earned more than 53.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,041 out of 13,032 | 54th |
Division Manufacturing | 2,185 out of 4,966 | 56th |
Major group Chemicals And Allied Products | 729 out of 1,686 | 57th |
Industry group Drugs | 567 out of 1,365 | 59th |
Industry Pharmaceutical Preparations | 437 out of 1,043 | 58th |
Source: SEC filing on February 24, 2017.
Suzdak's colleagues
We found two more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2014.